Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Analysts at Bank of America

Bank of America began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a report published on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $30.00 target price on the stock.

A number of other analysts also recently issued reports on the stock. Wolfe Research began coverage on shares of Kestra Medical Technologies in a report on Monday. They set an “outperform” rating and a $29.00 price target on the stock. Stifel Nicolaus assumed coverage on shares of Kestra Medical Technologies in a report on Monday. They issued a “buy” rating and a $28.00 target price on the stock. Piper Sandler started coverage on shares of Kestra Medical Technologies in a research note on Monday. They set an “overweight” rating and a $27.00 target price for the company. The Goldman Sachs Group began coverage on Kestra Medical Technologies in a report on Monday. They set a “neutral” rating and a $24.00 price target on the stock. Finally, Wells Fargo & Company began coverage on Kestra Medical Technologies in a research report on Monday. They set an “overweight” rating and a $28.00 price objective for the company. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $27.67.

Kestra Medical Technologies Stock Performance

Kestra Medical Technologies stock opened at $24.92 on Monday. Kestra Medical Technologies has a one year low of $20.00 and a one year high of $25.98.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.